Key Event Details
The company has received approval for change of name from "Bansisons Tea Industries Limited" to "Novyra Pharmachem Limited" on 22nd August 2026. This approval was pursuant to an application dated 16th July 2026.
Effective Date
The Certificate of Incorporation pursuant to change of name was issued by the Registrar of Companies, Central Processing Centre on 19th January 2026. The change of name is effective from this date.
Strategic Rationale
The name change marks a key milestone in the company's expansion into pharmaceutical, life sciences, and contract services sectors. The new business focus includes:
- Manufacturing, processing, and global trading of active pharmaceutical ingredients (APIs)
- Bulk drugs, intermediates, and specialty chemicals
- Establishment of advanced research laboratories
- Implementation of eco-efficient green chemistry practices
- Comprehensive contract research (CRO), development, and manufacturing (CDMO) services
Next Steps
The company will undertake necessary steps to update its name with:
- Stock exchanges
- Depositories
- Other statutory authorities
The disclosure was signed by Anit RUSSuthg, Managing Director (DIN: 11339148).